Advanced Search

 

Study ID Status Title Patient Level Data
205724 Recruiting Randomised, Double-Blind (Sponsor Open), Placebo-Controlled, Multicentre, Dose Ranging Study to Evaluate the Efficacy and Safety of Danirixin Tablets Administered Twice Daily Compared With Placebo for 24 Weeks in Adult Participants With Chronic Obstructive Pulmonary Disease (COPD)
205730 Not yet recruiting An open-label, randomised, single-dose, two-period cross-over study to evaluate bioequivalence of GR37547 ciprofloxacin 500 mg tablet versus ciprofloxacin 500 mg tablet reference product in healthy adult participants under fasting conditions
205744 Not yet recruiting A phase I/II, open-label, 2 arm study to investigate the safety, clinical activity, pharmacokinetics and pharmacodynamics of GSK2879552 administered alone or in combination with azacitidine, in adult subjects with IPSS-R high and very high risk myelodysplastic syndromes (MDS) previously treated with hypomethylating agents (HMA)
205759 Completed A single center, double-blind, randomized, placebo-controlled, parallel, single and repeat, dose-ascending study to evaluate the safety, tolerability and pharmacokinetics of GSK2269557 administered via the ELLIPTA™ dry powder inhaler to healthy Japanese subjects
205787 Completed Assessment of Patients Treated with Albiglutide - Phase 1
205794 Completed A Study to Evaluate the Efficacy of an Experimental Occlusion Technology Dentifrice in the Relief of Dentinal Hypersensitivity
205795 Completed Sun Protection Factor Determination (In vivo determination of the sun protection factor ISO 24444:2010(E))
205807 Not yet recruiting Observational Study to describe the Prevalence of Severe Asthma in Spanish Hospitals
205808 Completed A double-blind, randomized, placebo controlled, dose escalating crossover study to evaluate the safety, tolerability, pharmacokinetic and pharmacodynamic parameters of single doses of GSK2330672 in Japanese healthy male volunteers
205815 Not yet recruiting Horlicks Cardia+: investigating the glycaemic index and satiety effect of Horlicks Cardia+
205816 Not yet recruiting Discrete Choice Experiment in Severe Asthma
205832 Recruiting A Phase IIb, 24 week, randomized, double-blind, 3 arm parallel group study, comparing the efficacy, safety and tolerability of two doses of umeclidinium bromide administered once-daily via a dry powder inhaler, versus placebo, in participants with asthma
205846 Not yet recruiting PRJ2693: Descriptive Analysis of Neuropsychiatric Diagnoses in Patients taking Dolutegravir in the OPERA® Observational Database
205854 Not yet recruiting A Phase IV, randomized, open-label study to evaluate one year long-term persistence of immune responses following two different rabies vaccine post-exposure regimens (Zagreb 2-1-1 and Essen 1-1-1-1-1) in Chinese Children
205862 Active, not recruiting Claims-linked Survey Study to Assess Patient-reported COPD Symptoms and Burden of Illness among a Prevalent Population
205863 Not yet recruiting COPD Severity and Adherence to GOLD Guidelines in the Community Pharmacy Setting
205864 Not yet recruiting A randomized, double-blind, Sponsor open, placebo-controlled, 52 week study evaluating the effect of danirixin (GSK1325756) on lung function and health related quality of life in participants with mild to moderate Chronic Obstructive Pulmonary Disease (COPD)
205865 Completed Sun Protection Factor Determination: In vivo Determination of the Sun Protection Factor (SPF): ISO 24444:2010(E)
205875 Not yet recruiting A Post-Marketing Observational Study to Evaluate the Safety of Tykerb® in Chinese Patients
205905 Active, not recruiting A Phase 1, open label, non-randomized, single center study to evaluate the safety and immunogenicity of 1 booster vaccination with (GVGH Shigella sonnei 1790GAHB) vaccine administered intramuscularly in healthy adults previously primed with three doses of the same vaccine in study H03_01TP compared to 1 vaccination with (1790GAHB) administered intramuscularly either to subjects who received placebo in the H03_01TP study or naïve subjects who were not part of H03_01TP study
205907 Not yet recruiting Phenotypes of Severe Asthma among Adults in Brazil: a descriptive report of characteristics of subjects followed up in the ProAR Cohort
205911 Completed A single centre, double-blind, randomised, placebo-controlled, and single dose-ascending study to investigate the safety, tolerability, pharmacokinetics, and pharmacodynamics, of single intravenous doses of GSK2315698 in healthy Japanese subjects
205913 Active, Not Recruiting Subject Understanding of the Risks Associated with ZYBAN®, WELLBUTRIN®, WELLBUTRIN SR®, and WELLBUTRIN XL®
205915 Completed A Clinical Study to Evaluate the Ability of an Experimental Denture Adhesive to Prevent Food Particle Ingress Under Dentures
205920 Recruiting A randomized, open-label study to characterize the pharmacokinetics of inhaled oxytocin (GR121619) compared with IM oxytocin in women in the third stage of labour, and with IV oxytocin in non-pregnant, non-lactating women of childbearing potential

 

 

For more information on this register please email GSKClinicalSupportHD@gsk.com

GSK-sponsored clinical studies are those for which GSK is ultimately responsible for all aspects of the study even if some or all of these activities are transferred to another party.
GSK-sponsored clinical trials are those for which GSK is ultimately responsible for all aspects of the study even if some or all of these activities are transferred to another party.

ClinicalTrial.gov is a database that provides summary protocol information for ongoing clinical trials.

IFPMA.org is a search portal provided by the International Federation of Pharamceutical Manufacturers & Associations (IFPMA).

This portal provides a single entry point to search for industry sponsored clinical trials which are on existing registers and databases.

EU Clinical Trials Register is a database of all clinical trials commencing in the European Community from 1 May 2004 onwards. It has been established in accordance with Directive 2001/20/EC.